Skip to main content
Log in

Strategie per l’ablazione con radioiodio nei pazienti con carcinoma tiroideo a basso rischio

Strategies of radioiodine ablation in patients with low-risk thyroid cancer

  • Novità in Endocrinologia
  • Published:
L’Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Pubblicazioni di riferimento

  1. Hurley JR 2000 Management of thyroid cancer: radioiodine ablation, “stunning”, and treatment of thyroglobulinpositive, (131)I scan-negative patients. Endocr Pract 6: 401–406.

    Article  PubMed  CAS  Google Scholar 

  2. Lee J, Yun MJ, Nam KH, Chung WY, Soh EY, Park CS 2010 Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma. Thyroid 20: 173–179.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schlumberger, M., Catargi, B., Borget, I. et al. Strategie per l’ablazione con radioiodio nei pazienti con carcinoma tiroideo a basso rischio. L’Endocrinologo 13, 276 (2012). https://doi.org/10.1007/BF03346019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346019

Navigation